Methotrexate‐Induced Nephrotoxicity and Exposure Thresholds in Primary Central Nervous System Lymphoma: A Population PKPD Model

Documenti analoghi

• Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity
  di: Patrick O. Hanafin, et al.
  Pubblicazione: (2025)
• In the Cradle of Pharmacometric Methodology: Introducing Population PKPD Modeling, Simultaneous Analysis, and the Effect‐Compartment Model—Commentary on Sheiner et al.
  di: Mats O. Karlsson
  Pubblicazione: (2025)
• Mechanistic Modeling of Spatial Heterogeneity of Drug Penetration and Exposure in the Human Central Nervous System and Brain Tumors
  di: Jing Li, et al.
  Pubblicazione: (2024)
• From Classical PKPD to Model‐Informed Drug Development: Are “Digital Twins” a New Paradigm?
  di: Brett E. Houk
  Pubblicazione: (2026)
• Optimizing Brentuximab Vedotin Dosing in Pediatric Patients with Advanced Hodgkin Lymphoma: A Population Pharmacokinetic and Exposure‐Response Analysis
  di: Xiaofei Zhou, et al.
  Pubblicazione: (2025)